| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-06-29 19:51:07 UTC |
|---|
| Updated at | 2022-06-29 19:51:07 UTC |
|---|
| NP-MRD ID | NP0139364 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Salvicine |
|---|
| Description | Salvicine belongs to the class of organic compounds known as naphthoquinones. Naphthoquinones are compounds containing a naphthohydroquinone moiety, which consists of a benzene ring linearly fused to a bezene-1,4-dione (quinone). Salvicine was first documented in 2005 (PMID: 16483481). Based on a literature review a significant number of articles have been published on Salvicine (PMID: 30423952) (PMID: 32344256) (PMID: 32884211) (PMID: 25683888) (PMID: 35719997) (PMID: 33089727). |
|---|
| Structure | CC(C)C1=CC2=C(C(=O)C1=O)C(CCC(O)C(C)(C)O)=C(C)C=C2 InChI=1S/C20H26O4/c1-11(2)15-10-13-7-6-12(3)14(17(13)19(23)18(15)22)8-9-16(21)20(4,5)24/h6-7,10-11,16,21,24H,8-9H2,1-5H3 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C20H26O4 |
|---|
| Average Mass | 330.4240 Da |
|---|
| Monoisotopic Mass | 330.18311 Da |
|---|
| IUPAC Name | Not Available |
|---|
| Traditional Name | Not Available |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(C)C1=CC2=C(C(=O)C1=O)C(CCC(O)C(C)(C)O)=C(C)C=C2 |
|---|
| InChI Identifier | InChI=1S/C20H26O4/c1-11(2)15-10-13-7-6-12(3)14(17(13)19(23)18(15)22)8-9-16(21)20(4,5)24/h6-7,10-11,16,21,24H,8-9H2,1-5H3 |
|---|
| InChI Key | NZIUPDOWWMGNCV-UHFFFAOYSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as naphthoquinones. Naphthoquinones are compounds containing a naphthohydroquinone moiety, which consists of a benzene ring linearly fused to a bezene-1,4-dione (quinone). |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Naphthalenes |
|---|
| Sub Class | Naphthoquinones |
|---|
| Direct Parent | Naphthoquinones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Naphthoquinone
- Aryl ketone
- Quinone
- Tertiary alcohol
- Cyclic ketone
- Secondary alcohol
- Ketone
- 1,2-diol
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aromatic homopolycyclic compound
|
|---|
| Molecular Framework | Aromatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Lichota A, Gwozdzinski K: Anticancer Activity of Natural Compounds from Plant and Marine Environment. Int J Mol Sci. 2018 Nov 9;19(11). pii: ijms19113533. doi: 10.3390/ijms19113533. [PubMed:30423952 ]
- Kitdumrongthum S, Reabroi S, Suksen K, Tuchinda P, Munyoo B, Mahalapbutr P, Rungrotmongkol T, Ounjai P, Chairoungdua A: Inhibition of topoisomerase IIalpha and induction of DNA damage in cholangiocarcinoma cells by altholactone and its halogenated benzoate derivatives. Biomed Pharmacother. 2020 Jul;127:110149. doi: 10.1016/j.biopha.2020.110149. Epub 2020 Apr 25. [PubMed:32344256 ]
- Kirubhanand C, Selvaraj J, Rekha UV, Vishnupriya V, Sivabalan V, Manikannan M, Nalini D, Vijayalakshmi P, Rajalakshmi M, Ponnulakshmi R: Molecular docking analysis of Bcl-2 with phyto-compounds. Bioinformation. 2020 Jun 30;16(6):468-473. doi: 10.6026/97320630016468. eCollection 2020. [PubMed:32884211 ]
- Dwivedi UN, Tiwari S, Singh P, Singh S, Awasthi M, Pandey VP: Treponema pallidum putative novel drug target identification and validation: rethinking syphilis therapeutics with plant-derived terpenoids. OMICS. 2015 Feb;19(2):104-14. doi: 10.1089/omi.2014.0154. [PubMed:25683888 ]
- Dey D, Hasan MM, Biswas P, Papadakos SP, Rayan RA, Tasnim S, Bilal M, Islam MJ, Arshe FA, Arshad EM, Farzana M, Rahaman TI, Baral SK, Paul P, Bibi S, Rahman MA, Kim B: Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade. Front Oncol. 2022 Jun 1;12:899009. doi: 10.3389/fonc.2022.899009. eCollection 2022. [PubMed:35719997 ]
- Verma K, Mahalapbutr P, Auepattanapong A, Khaikate O, Kuhakarn C, Takahashi K, Rungrotmongkol T: Molecular dynamics simulations of sulfone derivatives in complex with DNA topoisomerase IIalpha ATPase domain. J Biomol Struct Dyn. 2022 Mar;40(4):1692-1701. doi: 10.1080/07391102.2020.1831961. Epub 2020 Oct 22. [PubMed:33089727 ]
- Gezici S, Sekeroglu N: Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents. Anticancer Agents Med Chem. 2019;19(1):101-111. doi: 10.2174/1871520619666181224121004. [PubMed:30582485 ]
- Sangpheak K, Mueller M, Darai N, Wolschann P, Suwattanasophon C, Ruga R, Chavasiri W, Seetaha S, Choowongkomon K, Kungwan N, Rungnim C, Rungrotmongkol T: Computational screening of chalcones acting against topoisomerase IIalpha and their cytotoxicity towards cancer cell lines. J Enzyme Inhib Med Chem. 2019 Dec;34(1):134-143. doi: 10.1080/14756366.2018.1507029. [PubMed:30394113 ]
- Zhang Y, Wang L, Chen Y, Qing C: Anti-angiogenic activity of salvicine. Pharm Biol. 2013 Aug;51(8):1061-5. doi: 10.3109/13880209.2013.776612. Epub 2013 Jun 10. [PubMed:23750780 ]
- Cai YJ, Lu JJ, Zhu H, Xie H, Huang M, Lin LP, Zhang XW, Ding J: Salvicine triggers DNA double-strand breaks and apoptosis by GSH-depletion-driven H2O2 generation and topoisomerase II inhibition. Free Radic Biol Med. 2008 Sep 1;45(5):627-35. doi: 10.1016/j.freeradbiomed.2008.05.017. Epub 2008 May 28. [PubMed:18582559 ]
- Zhou J, Chen Y, Lang JY, Lu JJ, Ding J: Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling. Mol Cancer Res. 2008 Feb;6(2):194-204. doi: 10.1158/1541-7786.MCR-07-0197. [PubMed:18314480 ]
- Cai Y, Lu J, Miao Z, Lin L, Ding J: Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells. Cancer Biol Ther. 2007 Nov;6(11):1794-9. doi: 10.4161/cbt.6.11.4860. Epub 2007 Aug 12. [PubMed:18032928 ]
- Zhang YW, Zhang ZX, Miao ZH, Ding J: The telomeric protein TRF2 is critical for the protection of A549 cells from both telomere erosion and DNA double-strand breaks driven by salvicine. Mol Pharmacol. 2008 Mar;73(3):824-32. doi: 10.1124/mol.107.039081. Epub 2007 Nov 19. [PubMed:18025071 ]
- Meng LH, Ding J: Salvicine, a novel topoisomerase II inhibitor, exerts its potent anticancer activity by ROS generation. Acta Pharmacol Sin. 2007 Sep;28(9):1460-5. doi: 10.1111/j.1745-7254.2007.00698.x. [PubMed:17723179 ]
- Narayanan BA: Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr Cancer Drug Targets. 2006 Dec;6(8):711-27. doi: 10.2174/156800906779010218. [PubMed:17168675 ]
- Hu CX, Zuo ZL, Xiong B, Ma JG, Geng MY, Lin LP, Jiang HL, Ding J: Salvicine functions as novel topoisomerase II poison by binding to ATP pocket. Mol Pharmacol. 2006 Nov;70(5):1593-601. doi: 10.1124/mol.106.027714. Epub 2006 Aug 16. [PubMed:16914642 ]
- Yao J, Feng FY, Lin C, Zhang XY, Fu M, Liang X, Yang Y: [The mechanism of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine) in a pancreatic cancer cell line]. Zhonghua Zhong Liu Za Zhi. 2005 Dec;27(12):721-6. [PubMed:16483481 ]
- Lu HR, Zhu H, Huang M, Chen Y, Cai YJ, Miao ZH, Zhang JS, Ding J: Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase. Mol Pharmacol. 2005 Oct;68(4):983-94. doi: 10.1124/mol.105.011544. Epub 2005 Jul 15. [PubMed:16024664 ]
- Lang JY, Chen H, Zhou J, Zhang YX, Zhang XW, Li MH, Lin LP, Zhang JS, Waalkes MP, Ding J: Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway. Clin Cancer Res. 2005 May 1;11(9):3455-64. doi: 10.1158/1078-0432.CCR-04-2026. [PubMed:15867248 ]
- Lu HR, Meng LH, Huang M, Zhu H, Miao ZH, Ding J: DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells. Cancer Chemother Pharmacol. 2005 Mar;55(3):286-94. doi: 10.1007/s00280-004-0877-z. Epub 2004 Nov 16. [PubMed:15592835 ]
|
|---|